Michel Sadelain
Immunologist and director at Center for Cell Engineering
Dr. Sadelain is founding director of the Center for Cell Engineering and head of the Gene Transfer and Gene Expression Laboratory at Memorial Sloan Kettering Cancer Center (MSKCC), where he holds the Stephen and Barbara Friedman Chair. He is also a member of the departments of medicine and pediatrics at Memorial Hospital and the molecular pharmacology and chemistry program of the Sloan Kettering Institute.
See also: Memorial Sloan Kettering Cancer Center - Cancer treatment and research institution in New York City
Details last updated 18-Jun-2020
Michel Sadelain News
2024 Breakthrough Prize honors medical innovations transforming lives
Breakthrough Prize Foundation - 14-Sep-2023
Game-changing treatments for cancer, cystic fibrosis, and parkinson’s
Read more...Nature Biotechnology reviews the state of play of senolytics
Nature Biotechnology - 12-Nov-2020
In August, Unity announced that its lead drug candidate had failed to beat a placebo in reducing ...
Read more...Genetically engineered T cells can be used to target and kill senescent cells
Medical Xpress - 17-Jun-2020
Tested successfully in mice with liver fibrosis and lung cancer
Read more...